Search

everythinglearnresearchcommunity

for

Search:↓

Further research is needed to improve hair regeneration using stem cells and nanomaterials.

Some diseases can improve the outcomes of other diseases, leading to new treatment possibilities.

Inflammation plays a key role in activating skin stem cells for hair growth and wound healing, but more research is needed to understand how it directs cell behavior.

The document concludes that managing side effects of MS therapies is crucial for treatment success and patient adherence.

Heparin and protamine are promising in tissue repair and organ regeneration, including skin and hair.

New treatments for lupus show promise, but more research is needed, especially for children.

New patents show progress in developing drugs targeting the Wnt pathway for diseases like cancer and hair loss.

A young woman had a rare skin reaction to a medication for her joint disease, and a combination therapy improved her condition.

The new chemotherapy combination of WP 631 and Epothilone B shows enhanced effectiveness against ovarian cancer but requires more research on its safety.

Skin reactions to drugs are common and can be deadly, usually requiring stopping the drug and may be better prevented with genetic testing in the future.

Drugmakers are optimistic about targeting the Wnt pathway for new treatments despite past challenges.

Tocilizumab therapy may cause skin and hair conditions like halo naevi, vitiligo, and alopecia areata.

Nanoparticles can speed up wound healing and deliver drugs effectively but may have potential toxicity risks.

New genes linked to ichthyosis were found, but there's still no cure; treatment options are improving.

The document concludes that the immune-inhibitory environment of the hair follicle may prevent melanoma development.

Chicken feather gene mutation helps understand human hair disorders.

Dermatologists are crucial for managing skin side effects in metastatic melanoma patients using vemurafenib and ipilimumab.

Thermography matched the patient's pain levels in a shingles case and might help diagnose shingles without a rash.

The top research priorities for congenital ichthyosis include long-term side effects of oral retinoids, best topical treatments, and treatments for itch and hair loss.

KLF4 is important for maintaining stem cells and has potential in cancer treatment and wound healing.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

Different drug doses approved in Japan and the U.S. are not mainly due to different clinical responses, and ethnic factors should be considered in setting drug doses.

Young HS patients often have other physical and mental health issues, and research on HS covers a wide range of topics including genetics, triggers, treatments, and the need for more data.

Nineteenth-century British drama closely reflected the era's societal values and concerns.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

Adalimumab is the most effective treatment for severe hidradenitis suppurativa, but more research is needed to improve treatment options.

COVID-19 can cause different skin issues, including rashes and hair loss.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

The 3D-SeboSkin model effectively simulates Hidradenitis suppurativa and is useful for future research.

Dermal Papilla Cells grown in 3D and with stem cells better mimic natural hair growth conditions than cells grown in 2D.